1. Home
  2. NTCT vs WVE Comparison

NTCT vs WVE Comparison

Compare NTCT & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTCT
  • WVE
  • Stock Information
  • Founded
  • NTCT 1984
  • WVE 2012
  • Country
  • NTCT United States
  • WVE Singapore
  • Employees
  • NTCT N/A
  • WVE N/A
  • Industry
  • NTCT EDP Services
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTCT Technology
  • WVE Health Care
  • Exchange
  • NTCT Nasdaq
  • WVE Nasdaq
  • Market Cap
  • NTCT 1.7B
  • WVE 1.7B
  • IPO Year
  • NTCT 1999
  • WVE 2015
  • Fundamental
  • Price
  • NTCT $19.84
  • WVE $5.92
  • Analyst Decision
  • NTCT Hold
  • WVE Strong Buy
  • Analyst Count
  • NTCT 1
  • WVE 11
  • Target Price
  • NTCT $25.00
  • WVE $22.00
  • AVG Volume (30 Days)
  • NTCT 544.7K
  • WVE 1.7M
  • Earning Date
  • NTCT 05-08-2025
  • WVE 05-08-2025
  • Dividend Yield
  • NTCT N/A
  • WVE N/A
  • EPS Growth
  • NTCT N/A
  • WVE N/A
  • EPS
  • NTCT N/A
  • WVE N/A
  • Revenue
  • NTCT $821,135,000.00
  • WVE $108,302,000.00
  • Revenue This Year
  • NTCT $0.22
  • WVE N/A
  • Revenue Next Year
  • NTCT $2.04
  • WVE N/A
  • P/E Ratio
  • NTCT N/A
  • WVE N/A
  • Revenue Growth
  • NTCT N/A
  • WVE N/A
  • 52 Week Low
  • NTCT $17.10
  • WVE $4.25
  • 52 Week High
  • NTCT $27.89
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • NTCT 39.59
  • WVE 33.76
  • Support Level
  • NTCT $19.73
  • WVE $5.28
  • Resistance Level
  • NTCT $20.69
  • WVE $6.41
  • Average True Range (ATR)
  • NTCT 0.83
  • WVE 0.62
  • MACD
  • NTCT 0.02
  • WVE -0.00
  • Stochastic Oscillator
  • NTCT 49.28
  • WVE 20.51

About NTCT NetScout Systems Inc.

NetScout Systems Inc is a provider of service assurance and cybersecurity solutions to enterprise and government networks. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: